このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Comparative Effects of Kinesio Taping on Cervical Pain in Climacteric Women (KT-Cerv-W)

2026年5月2日 更新者:GEMMA V ESPÍ LÓPEZ, PhD、University of Valencia

Comparative Study on the Effect of Kinesio Taping in Climacteric Women With Nonspecific Cervical Pain: ARandomized Clinical Trial.

This randomized controlled clinical trial aims to evaluate the effects of neuromuscular taping on cervical pain and health-related quality of life in climacteric women with non-specific chronic neck pain. Two taping techniques ("Y-strip" and "star-shape") will be compared with a control group receiving no intervention.

Participants will be randomly allocated to one of three groups following concealed allocation. The interventions will be applied to the cervicodorsal region (centered at C7) by an experienced physiotherapist over a 3-week period, with taping changes performed weekly. A 4-week total follow-up period will be included.

Primary and secondary outcomes will assess pain intensity, pressure pain threshold, cervical disability, cranio-cervical angle, pain perception, body satisfaction, and health-related quality of life. Measurements will be collected at baseline, weekly during the intervention, and at one-week post-intervention follow-up.

The study is designed to provide evidence on the effectiveness and feasibility of two non-invasive neuromuscular taping approaches in the management of chronic non-specific cervical pain in middle-aged women.

調査の概要

詳細な説明

This randomized controlled clinical trial is designed to investigate the effects of neuromuscular taping on pain, functional outcomes, and health-related quality of life in climacteric women with non-specific chronic cervical pain. The study compares two different neuromuscular taping applications ("Y-strip" and "star-shape") with a no-intervention control group.

Eligible participants will be women aged 45-65 years with non-specific cervical pain lasting more than three months, presenting mechanical pain characteristics and without clinical signs of specific pathology. After screening and baseline assessment, participants will be randomly allocated to one of the three study groups using a computer-generated randomization sequence with allocation concealment via sealed opaque envelopes.

Interventions will be applied to the cervicodorsal region, centered at the C7 vertebra, by an experienced physiotherapist following standardized protocols. The "Y-strip" technique will target the posterior cervical extensor muscles with directional and cross-taping components, while the "star-shape" technique will consist of four I-strips applied in a radial configuration over the cervicodorsal region. Tape will be replaced every 7 days during a 3-week intervention period. Participants in the control group will continue their usual daily activities without intervention.

Outcome measures will be assessed at five time points: baseline, week 1, week 2, week 3, and one-week post-intervention follow-up (week 4). The primary outcome is cervical pain intensity measured using an 11-point Numerical Rating Scale. Secondary outcomes include pressure pain threshold (measured in cervical and suboccipital muscles using algometry), cranio-cervical angle (assessed in seated and standing positions), neck disability (Neck Disability Index), pain perception (McGill Pain Questionnaire), body satisfaction and self-perception, and health-related quality of life (SF-8 Health Survey).

Pressure pain threshold data will be obtained through three repeated measurements per site and averaged for analysis, including a composite bilateral muscle score. The SF-8 will provide physical and mental component summaries of health status.

The study will employ a blinded outcome assessor, intention-to-treat analysis, and standardized measurement procedures. Participants will be blinded to group allocation, and medication use will not be restricted, although it will be recorded throughout the study period.

This trial aims to provide high-quality evidence regarding the clinical effectiveness of neuromuscular taping as a conservative intervention for chronic non-specific cervical pain and to determine whether different taping configurations produce differential therapeutic effects.

研究の種類

介入

入学 (推定)

50

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

  • 名前:Gemma Victoria Espi Lopez, PhD
  • 電話番号:+34651948635
  • メール:gemma.espi@uv.es

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

Female participants aged 45-65 years Non-specific musculoskeletal or osteoarticular cervical pain lasting more than 3 months Mechanical neck pain characteristics (pain influenced by movement or posture; absence of persistent non-mechanical nocturnal pain) Ability to understand the study procedures and provide written informed consent No clinical history or signs suggestive of specific cervical pathology

Exclusion Criteria:

Presence of any red flags Recent cervical trauma History of cancer or presence of constitutional symptoms (e.g., unexplained weight loss, fever, systemic malaise) Signs of infection or immunosuppression-related pain Active inflammatory disease Suspected vascular origin of symptoms (e.g., vertigo with cervical rotation, diplopia, dysarthria, vertebrobasilar symptoms, arterial dissection signs) Severe neurological involvement (e.g., progressive radiculopathy or signs of myelopathy) Relevant findings in previous imaging studies attributable to pain (routine imaging not required; only existing studies will be reviewed) Cervical surgery within the past 12 months Severe systemic diseases affecting the musculoskeletal system

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:トリプル

武器と介入

参加者グループ / アーム
介入・治療
介入なし:アーム 3
実験的:Arm 1
Participants will be allocated to neuromuscular taping using a "Y-strip" configuration applied to the cervicodorsal region.
Neuromuscular taping will be applied over the cervicodorsal region centered at C7. A Y-shaped tape will be placed over the posterior cervical extensor muscles with approximately 15-25% tension, plus an additional perpendicular I-strip over the mid-cervical region (C3-C6). Application will be performed in specific cervical positions to optimize muscle targeting. The tape will be replaced every 7 days. The intervention period will last 3 weeks, followed by 1 week of follow-up without intervention.
実験的:Arm 2
Participants will be allocated to neuromuscular taping using a "star-shape" configuration applied to the cervicodorsal region.
Neuromuscular taping will be applied over the cervicodorsal region centered at C7. Four I-strips will be placed with approximately 25% tension forming a star-shaped configuration over the treatment area. The tape will be replaced every 7 days. The intervention period will last 3 weeks, followed by 1 week of follow-up without intervention.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Cervical pain intensity
時間枠:Baseline, week 1, week 2, week 3, and week 4 (follow-up)
Cervical pain intensity will be assessed using an 11-point Numerical Rating Scale (NRS), where 0 indicates no pain and 10 indicates worst imaginable pain. Participants will rate their average cervical pain over the previous week.
Baseline, week 1, week 2, week 3, and week 4 (follow-up)

二次結果の測定

結果測定
メジャーの説明
時間枠
Pressure pain threshold (PPT)
時間枠:Baseline, week 1, week 2, week 3, and week 4 (follow-up)
Pressure pain threshold will be measured bilaterally in the upper trapezius, levator scapulae, and suboccipital muscles using a digital algometer (Wagner FDK 20). Three measurements per site will be recorded and averaged. A composite score will be calculated.
Baseline, week 1, week 2, week 3, and week 4 (follow-up)
Cranio-cervical angle
時間枠:Baseline, week 3, and week 4 (follow-up)
The cranio-cervical angle will be measured in seated and standing positions as the angle between a line from C7 to the tragus and a horizontal reference line through C7.
Baseline, week 3, and week 4 (follow-up)
Neck disability
時間枠:Baseline, week 3, and week 4 (follow-up)
The Neck Disability Index (NDI) is a 10-item questionnaire assessing self-reported disability related to cervical pain. Higher scores indicate greater disability.
Baseline, week 3, and week 4 (follow-up)
Pain perception
時間枠:Baseline, week 3, and week 4 (follow-up)
McGill Pain Questionnaire (short form). Pain perception will be assessed using the short-form McGill Pain Questionnaire, including Pain Rating Index (PRI), Present Pain Intensity (PPI), Number of Words Chosen (NWC), and Visual Analog Scale (VAS).
Baseline, week 3, and week 4 (follow-up)
Body satisfaction and self-perception
時間枠:Baseline, week 3, and week 4 (follow-up)
Body Satisfaction and Global Self-Perception Questionnaire (QSCPGSe). This questionnaire evaluates vitality, aesthetic perception, cognitive discomfort, and affective discomfort. Higher scores indicate greater body satisfaction.
Baseline, week 3, and week 4 (follow-up)
Health-related quality of life
時間枠:Baseline, week 3, and week 4 (follow-up)
SF-8 Health Survey. The SF-8 assesses eight domains of health-related quality of life (general health, physical functioning, role physical, bodily pain, vitality, social functioning, role emotional, and mental health). Physical (PCS) and mental (MCS) summary scores will be derived.
Baseline, week 3, and week 4 (follow-up)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年5月20日

一次修了 (推定)

2026年9月1日

研究の完了 (推定)

2026年9月30日

試験登録日

最初に提出

2026年5月2日

QC基準を満たした最初の提出物

2026年5月2日

最初の投稿 (実際)

2026年5月11日

学習記録の更新

投稿された最後の更新 (実際)

2026年5月11日

QC基準を満たした最後の更新が送信されました

2026年5月2日

最終確認日

2026年5月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

Individual participant data will not be shared due to privacy and data protection considerations.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する